Heparin Linked to Two Recent Deaths

The FDA is investigating the connection between two recent deaths at a Delaware hospital and tainted heparin. Just last year, 80 people tied as a result of receiving contaminated heparin.
Heparin, sold by Baxter International, is widely used in the United States and around the world as a blood thinner. Last year, heparin was the subject of a massive recall after it had been determined that it had been tainted with oversulfated chondroitin sulfate by manufacturers in China.
This time, the FDA believes the heparin was manufactured in China. Additionally, these two deaths involved patients with intracranial bleeding, not the allergic reactions linked to the Chinese contaminated heparin.
The FDA is testing the heparin bags but they don’t believe the recent deaths are related to what happened a year ago. The FDA is trying to determine the exact nature of the heparin-related deaths in Delaware.